GMO U.S. Value ETF (NYSEARCA:GMOV – Get Free Report) was the recipient of a large growth in short interest during the month of August. As of August 31st, there was short interest totaling 3,614 shares, a growth of 610.0% from the August 15th total of 509 shares. Based on an average daily trading volume, of 7,807 shares, the short-interest ratio is presently 0.5 days. Approximately 0.1% of the company’s stock are sold short.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the stock. HighTower Advisors LLC grew its stake in GMO U.S. Value ETF by 1.8% in the fourth quarter. HighTower Advisors LLC now owns 123,110 shares of the company’s stock valued at $3,384,000 after purchasing an additional 2,182 shares in the last quarter. MML Investors Services LLC bought a new stake in shares of GMO U.S. Value ETF during the 4th quarter worth approximately $1,794,000. Essential Partners LLC raised its stake in shares of GMO U.S. Value ETF by 8.6% during the 1st quarter. Essential Partners LLC now owns 60,238 shares of the company’s stock worth $1,692,000 after purchasing an additional 4,774 shares in the last quarter. StoneX Group Inc. acquired a new stake in shares of GMO U.S. Value ETF in the 4th quarter valued at approximately $1,536,000. Finally, Fund Evaluation Group LLC boosted its holdings in shares of GMO U.S. Value ETF by 7.4% in the 4th quarter. Fund Evaluation Group LLC now owns 50,500 shares of the company’s stock valued at $1,388,000 after buying an additional 3,500 shares during the last quarter.
GMO U.S. Value ETF Price Performance
Shares of NYSEARCA:GMOV opened at $32.59 on Friday. The company’s 50-day moving average price is $31.88 and its two-hundred day moving average price is $30.18. GMO U.S. Value ETF has a one year low of $25.66 and a one year high of $33.34. The stock has a market capitalization of $104.29 million, a PE ratio of 12.08 and a beta of 0.63.
GMO U.S. Value ETF Cuts Dividend
About GMO U.S. Value ETF
The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.
See Also
- Five stocks we like better than GMO U.S. Value ETF
- IBM and Lockheed Martin Turn a Swiss Defense Deal Into a Quantum Computing Bet
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
Receive News & Ratings for GMO U.S. Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
